top of page
eda_clinical_logo_edited_edited_edited_e

Help research and develop new drugs

Launch a new career within 6 months by getting real experience in an accelerated, immersive environment
Recycled Circle Badge _edited_edited.png
favicon_edited_edited_edited.png

16 to 24 weeks

3 Certifications

Real Teams

Real Trials

Real Tools

Real Interviews

Why Now? Innovation
  • Over 5,500 pharmaceutical companies with active pipelines 

  • Digitization driving demand: Electronic Data Capture (EDA) and Clinical Outcome Assessments (e-COA)

  • Decentralized/virtual trials and telemedicine

​Why EDA? Immersive
  • Authentic study teams, protocols and analysis plans

  • Standard tools and best practices to process clinical data 

  • Defend your results in real interviews with study sponsors  

Why you? Impressive
  • Advanced degree or achievement in a STEM field

  • Experience in R, Python, and/or SQL

  • Willingness to learn SAS programming and CDISC standards

Admission is highly competitive. The program offers limited seating with rolling admissions. The application deadline is June 15.

Get Experience

We simulate real clinical trials to help you grasp the step-by-step process of acquiring, standardizing, analyzing and submitting patient data. Work alongside data managers and statisticians, familiarizing yourself with common documents and procedures. Produce four Clinical Study Reports (CSRs), one for each Mock Trial, facing hidden challenges found in real scenarios. For each study, get direct feedback from lead programmers during code review, dry runs, and interim analyses as we approach "database lock", where final reports are submitted for scoring.

Get Certified

Prepare for three certification exams with hands-on practice: 1. Base SAS Specialist Programming 2. SAS Clinical Trials Programming 3. CDISC Tabulate Our online resources and on-site staff are available to support your progress. Note: It's advised to achieve at least one certification before Orientation Day due to the program's rapid pace. EDA has no affiliation with SAS or CDISC.

Get Interviewed

After receiving your exam scores and completing your Clinical Study Reports (CSRs), you will respond to "information requests" from interviewers. These requests simulate real-life situations where regulatory agencies question a study sponsor's submission. They offer a chance to showcase your comprehension of the analysis, trial result accuracy, and adherence to submission standards. Companies aim to impartially evaluate your skills as a statistical programmer in clinical trial contexts. Our controlled simulations serve this exact purpose.

Get Hired

We want to establish long-term working relationships. After your interviews, rank your opportunities using various criteria to help us identify where interests align, and then select from your top matches. You will also have the opportunity to consult with our advisors and connect with our partners at sponsored events. We will help you build networks, interview, and improve your job search even after graduation and job placement!

Deliver Results

Each deliverable becomes an opportunity for you to improve components of each Clinical Study Report before their final due date.
"Collecting data from multiple remote sources may require strong data management skills and data management platforms."

Leonard Sacks, MD, Associate Director for Clinical Methodology in CDER’s Office of Medical Policy 
The Evolving Role of Decentralized Clinical Trials and Digital Health Technologies | FDA

Structured 


Avoid the pitfalls of online learning and experience a structured atmosphere that is tailored to onboard you into a specific job

​

  • Ensure you remain on course with our daily meetups and open office hours while receiving weekly reports to celebrate your progress.
     

  • Deliver four comprehensive clinical study reports with your teammates, spanning across all four phases of clinical research and exploring diverse therapeutic areas.
     

  • Apply data standards and execute statistical analysis plans to prepare for examinations and earn widely recognized and highly valued certifications.
     

  • Use your credentials to confidently present and defend your results during the interview process, paving the way to a new career in clinical research.

     

Realistic


Your portfolio at EDA represents the components of the Clinical Study Report, a comprehensive document that summarizes the results and findings of a clinical trial.  

​​

  • Follow standard operating procedures which represent the same processes that employers have.
     

  • Utilize special tools for data management, programming and development, not publicly available although well-established in industry.
     

  • Access authentic study documents, including Statistical Analysis Plans and protocols, to produce CSRs that are verified for accuracy and compliance, akin to genuine clinical trial submissions.

​

  • Address "unexpected" errors strategically designed to hone critical thinking skills and equip candidates for handling interviews.

Professional


Understand the wide and varied responsibilities of a statistical programmer alongside other members of the study team 

​

  • Each study is assigned a lead programmer who offers one-on-one mentorship to help you achieve your goals, learn effective programming practices, stay focused, and master the delivery of first-time quality work.

​

  • Apprentices collaborate with Statisticians and Data Managers to ensure deliverables are completed with a high level of confidence in their quality.

​

  • Our network of mentors help you plan, search, interview, and negotiate successfully — available even after you complete the program, whenever you are ready for your next challenge.

​

  • Connect with fellow Apprentices online where you can access forums, share files, and receive feedback on your projects.

Transform clinical data
into life-saving solutions

​Managing clinical data from the start to the finish of a trial offers the appropriate context for programmers who are new to the field.
infectious disease, microbial, high resolution, zoomed in.jpg

Phase I Study: 
mRNA Vaccine plus Immunotherapy in Subjects with Solid Tumors

Phase I studies typically recruit healthy volunteers to evaluate the safety, tolerability, and pharmacokinetics of new treatments. However, Phase I oncological studies often enroll patients who have exhausted standard treatment options for advanced or metastatic cancer. In this study exploring a therapeutic combination of an mRNA vaccine and immunotherapy, researchers hope to enhance anti-tumor activity, minimize toxicity, and delay or prevent disease progression.

peering into petri dish, ultra realistic, high resolution, enlightening.jpg

Phase II Study: 
Immunogenicity, Safety and Tolerability of Chikungunya Vaccine in Healthy Subjects

Phase II studies evaluate promising treatments with more patients. They typically recruit patients with the specific disease or condition of interest. However, when developing a vaccine against a mosquito-borne virus, the treatment will ultimately be administered to healthy subjects at risk of infection, in order to keep them healthy by preventing the target disease. Therefore, healthy volunteers are recruited to test the vaccine's safety and tolerability, as well as its immunogenicity - which is key to its ability to prevent infection.

Davinci style sketch of medical device implanted into hand, futuristic photo, ultra realis

Phase III Study: 
Non-invasive Device to Alleviate Carpal Tunnel Syndrome, a Decentralized Trial

Medical devices exist for a multitude of uses, from diagnostics to prevention and treatment. Unlike pharmaceuticals, which often undergo rigorous phase III clinical trials to demonstrate safety and efficacy, the regulatory pathway for medical devices varies based on factors such as the risk classification of the device and the specifics of its intended use. In some cases, clinical data from smaller studies or bench testing may be sufficient to support marketing approval for lower-risk devices.

medical device, cardiology, ultra realistic, implant, translucent, photo.jpg

Phase IV Study: 
Anticoagulant Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism

Phase IV studies, also known as post-marketing surveillance trials, assess the real-world effectiveness and safety of treatments after they have been approved and are in widespread clinical use. Typical Phase IV studies involve a larger patient population and longer follow-up periods to gather data on rare adverse events and better understand the treatment's performance in routine clinical practice.

Orientation Day
Pittsburgh, PA

Pittsburgh has world-class facilities and a supportive technical community. Carnegie Mellon University (CMU) and the University of Pittsburgh are famous for their cutting-edge research in robotics, AI, biotechnology, and healthcare. The University of Pittsburgh Medical Center (UPMC) and Allegheny Health Network are actively engaged in clinical trials. 

Any questions? 

You can reach us Monday to Friday from 8am - 6pm EST by calling +1 412 405 1447

balanced, transparent, translucent, biologic, microscopic, colloidial, ultra realisitic, f

 Limited Seats 

eda_clinical_logo_edited_edited_edited_e

Copyright 2024

bottom of page